| Bioactivity | [Tyr0] Gastric Inhibitory Peptide (23-42), human, a glucose-dependent insulinotropic polypeptide (GIP), is a weak inhibitor of gastric acid secretion that also stimulates insulin secretion. [Tyr0] Gastric Inhibitory Peptide (23-42), human can be used in diabetes, obesity research[1][2]. |
| Name | [Tyr0] Gastric Inhibitory Peptide (23-42), human |
| CAS | 121765-67-1 |
| Shortening | YVNWLLAQKGKKNDWKHNITQ |
| Formula | C119H182N34O31 |
| Molar Mass | 2584.93 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
[Tyr0] Gastric Inhibitory Peptide (23-42), human
CAS: 121765-67-1 F: C119H182N34O31 W: 2584.93
Gastric Inhibitory Peptide (23-42), human, a glucose-dependent insulinotropic polypeptide (GIP), is a weak inhibitor of
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.